Cargando…

Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study

BACKGROUND: To date, there has been no comprehensive study on the association between atrial fibrillation (AF) and multimorbidity. The present study investigated the epidemiology of AF and the association between multimorbidity and the onset of AF. In addition, the correlation between multimorbidity...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanbeselaere, Vigdis, Truyers, Carla, Elli, Steven, Buntinx, Frank, De Witte, Harrie, Degryse, Jan, Henrard, Séverine, Vaes, Bert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810573/
https://www.ncbi.nlm.nih.gov/pubmed/27021333
http://dx.doi.org/10.1186/s12872-016-0235-1
_version_ 1782423834288193536
author Vanbeselaere, Vigdis
Truyers, Carla
Elli, Steven
Buntinx, Frank
De Witte, Harrie
Degryse, Jan
Henrard, Séverine
Vaes, Bert
author_facet Vanbeselaere, Vigdis
Truyers, Carla
Elli, Steven
Buntinx, Frank
De Witte, Harrie
Degryse, Jan
Henrard, Séverine
Vaes, Bert
author_sort Vanbeselaere, Vigdis
collection PubMed
description BACKGROUND: To date, there has been no comprehensive study on the association between atrial fibrillation (AF) and multimorbidity. The present study investigated the epidemiology of AF and the association between multimorbidity and the onset of AF. In addition, the correlation between multimorbidity and the use of anticoagulants and the risk of cerebrovascular events considering multimorbidity was explored in AF patients. METHODS: Intego is a primary care registry network in Belgium. A case–control study was performed using Intego data from a 10-year time interval (2002 to 2011). All patients aged 60 years and older in 2002 who had developed new AF between 2002 and 2011 were selected, as well as a group of matched control patients. In addition, the prescription of anticoagulants and incident cerebrovascular events were recorded in patients with AF. RESULTS: AF showed a prevalence of 5.3 % in 2002, and an upward trend was observed between 2002 and 2011. In all, 1830 patients with AF and 6622 control patients were included. AF patients had significantly more comorbidities (mCCI (modified Charlson Comorbidity Index) 5 ± 2 vs 4 ± 2, P < 0.001). In addition, 9.7 % of patients with AF developed a cerebrovascular event (mean follow-up time of 2.7 ± 2.5 years). Both the under- and overuse of anticoagulants was observed. Of the 49 % of patients with AF who were considered at high risk (CHADS(2) ≥ 2), 50 % received anticoagulants in the first six months after diagnosis, whereas 49 % of patients who were at low risk (CHADS(2) = 0) did not. CONCLUSIONS: AF is highly prevalent in older primary care patients and is significantly associated with multimorbidity. A discrepancy between the guidelines and clinical practice of anticoagulant use was observed. As multimorbidity seems to play a role in this, further qualitative research to study the perception and motives of the general practitioner is needed.
format Online
Article
Text
id pubmed-4810573
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48105732016-03-30 Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study Vanbeselaere, Vigdis Truyers, Carla Elli, Steven Buntinx, Frank De Witte, Harrie Degryse, Jan Henrard, Séverine Vaes, Bert BMC Cardiovasc Disord Research Article BACKGROUND: To date, there has been no comprehensive study on the association between atrial fibrillation (AF) and multimorbidity. The present study investigated the epidemiology of AF and the association between multimorbidity and the onset of AF. In addition, the correlation between multimorbidity and the use of anticoagulants and the risk of cerebrovascular events considering multimorbidity was explored in AF patients. METHODS: Intego is a primary care registry network in Belgium. A case–control study was performed using Intego data from a 10-year time interval (2002 to 2011). All patients aged 60 years and older in 2002 who had developed new AF between 2002 and 2011 were selected, as well as a group of matched control patients. In addition, the prescription of anticoagulants and incident cerebrovascular events were recorded in patients with AF. RESULTS: AF showed a prevalence of 5.3 % in 2002, and an upward trend was observed between 2002 and 2011. In all, 1830 patients with AF and 6622 control patients were included. AF patients had significantly more comorbidities (mCCI (modified Charlson Comorbidity Index) 5 ± 2 vs 4 ± 2, P < 0.001). In addition, 9.7 % of patients with AF developed a cerebrovascular event (mean follow-up time of 2.7 ± 2.5 years). Both the under- and overuse of anticoagulants was observed. Of the 49 % of patients with AF who were considered at high risk (CHADS(2) ≥ 2), 50 % received anticoagulants in the first six months after diagnosis, whereas 49 % of patients who were at low risk (CHADS(2) = 0) did not. CONCLUSIONS: AF is highly prevalent in older primary care patients and is significantly associated with multimorbidity. A discrepancy between the guidelines and clinical practice of anticoagulant use was observed. As multimorbidity seems to play a role in this, further qualitative research to study the perception and motives of the general practitioner is needed. BioMed Central 2016-03-28 /pmc/articles/PMC4810573/ /pubmed/27021333 http://dx.doi.org/10.1186/s12872-016-0235-1 Text en © Vanbeselaere et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Vanbeselaere, Vigdis
Truyers, Carla
Elli, Steven
Buntinx, Frank
De Witte, Harrie
Degryse, Jan
Henrard, Séverine
Vaes, Bert
Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study
title Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study
title_full Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study
title_fullStr Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study
title_full_unstemmed Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study
title_short Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study
title_sort association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810573/
https://www.ncbi.nlm.nih.gov/pubmed/27021333
http://dx.doi.org/10.1186/s12872-016-0235-1
work_keys_str_mv AT vanbeselaerevigdis associationbetweenatrialfibrillationanticoagulationriskofcerebrovasculareventsandmultimorbidityingeneralpracticearegistrybasedstudy
AT truyerscarla associationbetweenatrialfibrillationanticoagulationriskofcerebrovasculareventsandmultimorbidityingeneralpracticearegistrybasedstudy
AT ellisteven associationbetweenatrialfibrillationanticoagulationriskofcerebrovasculareventsandmultimorbidityingeneralpracticearegistrybasedstudy
AT buntinxfrank associationbetweenatrialfibrillationanticoagulationriskofcerebrovasculareventsandmultimorbidityingeneralpracticearegistrybasedstudy
AT dewitteharrie associationbetweenatrialfibrillationanticoagulationriskofcerebrovasculareventsandmultimorbidityingeneralpracticearegistrybasedstudy
AT degrysejan associationbetweenatrialfibrillationanticoagulationriskofcerebrovasculareventsandmultimorbidityingeneralpracticearegistrybasedstudy
AT henrardseverine associationbetweenatrialfibrillationanticoagulationriskofcerebrovasculareventsandmultimorbidityingeneralpracticearegistrybasedstudy
AT vaesbert associationbetweenatrialfibrillationanticoagulationriskofcerebrovasculareventsandmultimorbidityingeneralpracticearegistrybasedstudy